gms | German Medical Science

69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

03.06. - 06.06.2018, Münster

When to screen patients for the need of psychooncological intervention?

Meeting Abstract

  • Jörn Krämer - Universitätsklinikum Mannheim, Universität Heidelberg, Klinik für Neurochirurgie, Mannheim, Deutschland
  • Alida Finze - Universitätsklinikum Mannheim, Universität Heidelberg, Klinik für Neurochirurgie, Mannheim, Deutschland
  • Laura Deleanu - Universitätsklinikum Mannheim, Universität Heidelberg, Klinik für Neurochirurgie, Mannheim, Deutschland
  • Miriam Ratliff - Universitätsklinikum Mannheim, Universität Heidelberg, Klinik für Neurochirurgie, Mannheim, Deutschland
  • Daniel Hänggi - Universitätsklinikum Mannheim, Universität Heidelberg, Klinik für Neurochirurgie, Mannheim, Deutschland
  • Marcel Seiz-Rosenhagen - Universitätsklinikum Mannheim, Universität Heidelberg, Klinik für Neurochirurgie, Mannheim, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie. Münster, 03.-06.06.2018. Düsseldorf: German Medical Science GMS Publishing House; 2018. DocV235

doi: 10.3205/18dgnc239, urn:nbn:de:0183-18dgnc2392

Published: June 18, 2018

© 2018 Krämer et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: The aim of the ongoing study is to figure out the best time for a psycho-oncological screening in brain tumor patients. The question is whether a single screening at the beginning of the admission is appropriate and sufficient for detecting psychological stress or if the emotional state in patients has to be reevaluated during the hospital stay. The struggle with a malignant diagnosis is handled differently by patients; thus predictors for intense need of psycho-oncological support would be beneficial.

Methods: So far 26 patients participated in the study. Standardized questionnaires were used to measure patients psychological stress level, family situation and social support as well as cognitive skills several times during their hospital stay and once after discharge.

Results: Regardless of the expected tumor dignity, all patients showed signs of a mild depression with increasing symptoms during their hospital stay. After being informed about the diagnosis (benign vs. malignant) the above-mentioned fact did not change significantly. At the end of the observation period of about 6 weeks, depression scores slowly declined. As expected, patients with a strong social support show fewer symptoms and were less likely in need of psycho-oncological support.

Conclusion: A single screening early after admission is not sufficient to detect if the patient would benefit from counselling in order to reduce emotional stress.Regardless of the tumor dignity, patients should be informed about the possibility of psycho-oncological support at the beginning of their hospital stay. We suggest for all patients to undergo a psycho-oncologic screening after being informed of their histopathological diagnosis. We recommend awareness for typical signs of depression onset in order to offer intervention immediately.